Home » Raptiva

Receive a free case review.

Raptiva

Raptiva, which has the generic name efalizumab, is a prescription Raptivamedication used to treat moderate to severe psoriasis. Raptiva is administered as an injection once a week and may be injected into the thigh, abdomen, upper arm, or buttocks. Manufactured by Genentech Inc., Raptiva has been on the market since it received FDA approval in 2003.

Raptiva & Psoriasis Treatment

Psoriasis is a chronic skin condition involving the abnormal growth of new skin cells in patches called plaques, resulting in scaling and inflammation of the skin. Raptiva, which is known as an immunosuppressant, works by blocking the immune cells that cause these psoriasis plaques to develop.

Important Info about Raptiva

Related Topics:

Dangerous Product Alert:

Legal News:

Treatment with an immunosuppressant, such as Raptiva, may increase the risk of developing certain types of cancer (e.g. lymphoma). Additionally, Raptiva may cause serious, and potentially fatal, infections. Raptiva patients should contact a doctor immediately if they develop the symptoms of infection, such as:

  • fever or chills
  • sore throat
  • coughing
  • congestion
  • redness, pain, or swelling of a skin wound
  • burning or difficult urination

Raptiva may also cause a decreased number of platelets in the blood, which could result in bleeding. Raptiva patients should contact a doctor immediately if they display symptoms of low platelets, such as:

  • unusual bruising or bleeding
  • pinpoint red spots under the skin
  • easy bleeding from the gums
  • nosebleeds
  • black, bloody or tarry stools

For some people, Raptiva may actually cause new or worsening cases of psoriasis. Raptiva patients who develop a rash, skin condition, or worsening psoriasis during treatment with Raptiva should contact a doctor.

Raptiva Side Effects Attorneys

On October 16, 2008, the FDA ordered Genentech to add a black box warning to the Raptiva label about Raptiva’s association with serious infections, including the deadly brain disease progressive multifocal leukoencephalopathy (PML). During its short time on the market, Raptiva has been linked to several serious side effects, including pneumonia, meningitis and cancer.

If you or a family member developed serious side effects after using Raptiva, you may be entitled to compensation for your injuries. Contact us today for a free and confidential case evaluation.



Our Areas of Practice

Raptiva Quick Facts

Raptiva Quick Reference Guide
Other Names:

Efalizumab

Date Approved:
2003

Manufacturer:
Genentech

Status:
On the market

Approved Uses:
Psoriasis

Off-Label Uses:
n/a

Serious Side Effects:
Serious infections
Cancer
Worsening psoriasis

Common Misspellings:
Rapteva
Rapteeva